OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
42 hedge funds and large institutions have $12.1M invested in Orexigen Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
42
Holding in Top 10
–
Calls
$651K
Puts
$533K
Top Buyers
| 1 | +$248K | |
| 2 | +$194K | |
| 3 | +$104K | |
| 4 |
VF
Virtu Financial
New York
|
+$63K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$32.5K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$348K | |
| 3 | -$204K | |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$167K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$61K |